Scanlon Dennis P, Chernew Michael, Swaminathan Shailender, Lee Woolton
Pennsylvania State University, USA.
Med Care Res Rev. 2006 Dec;63(6 Suppl):37S-55S. doi: 10.1177/1077558706293834.
Health care reform proposals often rely on increased competition in health insurance markets to drive improved performance in health care costs, access, and quality. We examine a range of data issues related to the measures of health insurance competition used in empirical studies published from 1994-2004. The literature relies exclusively on market structure and penetration variables to measure competition. While these measures are correlated, the degree of correlation is modest, suggesting that choice of measure could influence empirical results. Moreover, certain measurement issues such as the lack of data on PPO enrollment, the treatment of small firms, and omitted market characteristics also could affect the conclusions in empirical studies. Importantly, other types of measures related to competition (e.g., the availability of information on price and outcomes, degree of entry barriers, etc.) are important from both a theoretical and policy perspective, but their impact on market outcomes has not been widely studied.
医疗保健改革提案通常依赖于增强医疗保险市场的竞争,以推动在医疗保健成本、可及性和质量方面取得更好的表现。我们研究了一系列与1994年至2004年发表的实证研究中所使用的医疗保险竞争度量相关的数据问题。该文献完全依赖于市场结构和渗透率变量来衡量竞争。虽然这些度量是相关的,但相关程度适中,这表明度量的选择可能会影响实证结果。此外,某些测量问题,如缺乏优先提供者组织(PPO)参保数据、对小企业的处理以及遗漏的市场特征,也可能影响实证研究的结论。重要的是,从理论和政策角度来看,与竞争相关的其他类型的度量(例如,价格和结果信息的可获得性、进入壁垒程度等)很重要,但它们对市场结果的影响尚未得到广泛研究。